Fibrinolytic activity and clotting factors in ischaemic heart disease in women.
作者信息
Meade T W, Cooper J A, Chakrabarti R, Miller G J, Stirling Y, Howarth D J
机构信息
MRC Epidemiology and Medical Care Unit, Wolfson Institute of Preventive Medicine, Bartholomew's, London.
出版信息
BMJ. 1996 Jun 22;312(7046):1581.
Abstract
摘要
相似文献
1
Fibrinolytic activity and clotting factors in ischaemic heart disease in women.女性缺血性心脏病中的纤溶活性和凝血因子
BMJ. 1996 Jun 22;312(7046):1581.
2
Factor-VII activity and ischaemic heart disease: fatal and non-fatal events.
QJM. 1994 Jul;87(7):403-6.
3
Haemostatic variables in Pacific Islanders apparently free from stroke and ischaemic heart disease--the Kitava Study.
Thromb Haemost. 1997 Jan;77(1):94-8.
4
5
Effects of age on fibrinolytic activity and factors V, VII and VIII.年龄对纤溶活性及因子V、VII和VIII的影响。
Proc R Soc Med. 1975 Apr;68(4):267-8. doi: 10.1177/003591577506800439.
6
Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone: Kuopio Ischaemic Heart Disease Risk Factor Study.根据肠内酯血清浓度评估心血管疾病相关死亡和全因死亡风险：库奥皮奥缺血性心脏病危险因素研究
Arch Intern Med. 2003 May 12;163(9):1099-104. doi: 10.1001/archinte.163.9.1099.
7
Variation between batches in clotting factor assays.
Thromb Haemost. 1982 Dec 27;48(3):274-6.
8
9
Sex differences in the determinants of fibrinolytic activity.纤溶活性决定因素中的性别差异。
Thromb Haemost. 1998 Mar;79(3):587-90.
10
Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.在一项心肌梗死前瞻性研究（PRIME研究，即心肌梗死前瞻性流行病学研究）的10500名男性参与者中，纤维蛋白原、凝血因子VII和纤溶酶原激活物抑制剂-1与基线检查结果的相关性。
Thromb Haemost. 1998 Nov;80(5):749-56.
引用本文的文献
1
Reduced fibrinogen, fibrinolytic biomarkers, and physical parameters after a weight-loss program in obese subjects.肥胖受试者进行减肥计划后纤维蛋白原、纤溶生物标志物及身体参数降低。
N Am J Med Sci. 2014 Aug;6(8):377-82. doi: 10.4103/1947-2714.139286.
2
Cardiovascular complications of obesity in adolescents.青少年肥胖的心血管并发症
J Endocrinol Invest. 2007 Jan;30(1):70-80. doi: 10.1007/BF03347399.
3
Fibrinolytic potential is significantly increased by oestrogen treatment in postmenopausal women with mild dyslipidaemia.雌激素治疗可显著提高轻度血脂异常的绝经后女性的纤溶潜力。
Heart. 1998 Sep;80(3):235-9. doi: 10.1136/hrt.80.3.235.
本文引用的文献
1
Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men.纤维蛋白原和凝血因子VII对冠心病风险的预测作用。来自健康男性前瞻性心血管 Münster 研究（PROCAM）的结果
Arterioscler Thromb. 1994 Jan;14(1):54-9. doi: 10.1161/01.atv.14.1.54.
2
Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study.诺斯威克公园心脏研究中的纤溶活性、凝血因子与缺血性心脏病的长期发病率
Lancet. 1993 Oct 30;342(8879):1076-9. doi: 10.1016/0140-6736(93)92062-x.
3
Fibrinolytic activity and arterial disease.纤维蛋白溶解活性与动脉疾病
Lancet. 1994 Jun 4;343(8910):1442. doi: 10.1016/s0140-6736(94)92572-0.
4
Factor VIII, ABO blood group and the incidence of ischaemic heart disease.凝血因子VIII、ABO血型与缺血性心脏病的发病率
Br J Haematol. 1994 Nov;88(3):601-7. doi: 10.1111/j.1365-2141.1994.tb05079.x.
5
Fibrinogen and risk of cardiovascular disease. The Framingham Study.纤维蛋白原与心血管疾病风险。弗明汉姆研究。
JAMA. 1987 Sep 4;258(9):1183-6.
Zotero 插件